Contrary to this, intraperitoneal administration of GLP-1 agonists does not stimulate vagal afferents 33 , only a small subset of GLP-1R-expressing vagal afferents innervate the intestinal mucosa where GLP-1 cells reside 33,34 , and ablation of vagal GLP-1R neurons doesnt prevent GLP-1Rs satiating effects 35
In: Jameson J, De Groot L, eds
These drugs are homologous (53% and 97% respectively) to natural GLP-1, with the added benefit of resistance to degradation by DPP-4 which enhances their half-life
If you experience severe or prolonged symptoms, contact your provider
While tirzepatide itself is FDA-approved (as Mounjaro and Zepbound), the combination with levocarnitine is a compounded product that has not undergone FDA review for safety or efficacy